ArticleThe AAPS journal2022

Tumor Growth Inhibition-Overall Survival (TGI-OS) Model for Subgroup Analysis Based on Post-Randomization Factors: Application for Anti-drug Antibody (ADA) Subgroup Analysis of Atezolizumab in the IMpower150 Study.

Kenta Yoshida et al.PubMed ↗Publisher ↗

No numbers read from the abstract.